Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Gastrointestinal Motility Disorders

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

Irritable Bowel Syndrome III: Medical and Nursing Management

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Brain Changes Underlying Irritable Bowel Syndrome Symptom Improvement in Response to Mindfulness-Based Stress Reduction.

Neurogastroenterology and motility·2026

Same author

Role of Sex, Anxiety, and Resilience in the Association Between Adverse Childhood Experiences and Irritable Bowel Syndrome.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2024

Same author

Neural correlates of perceived and relative resilience in male and female patients with irritable bowel syndrome.

Neurogastroenterology and motility·2023

Same author

Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.

Microbiome·2023

Same author

Sex-specific brain microstructural reorganization in irritable bowel syndrome.

Pain·2022

Same author

Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.

Microbiome·2021

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Complementary and alternative medicine for gastrointestinal disorders.

Kirsten Tillisch¹

¹Center for Neurovisceral Sciences and Women's Health, David Geffen School of Medicine, University of California-Los Angeles, CA 90095, USA. ktillisch@mednet.ucla.edu

Clinical Medicine (London, England)

|July 20, 2007

Summary

Complementary and alternative medicine (CAM) offers growing options for gastrointestinal and liver conditions. Further research is needed to integrate effective CAM therapies into conventional Western medical practice for improved patient outcomes.

Related Experiment Videos

Last Updated: Jul 13, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

Area of Science:

Gastroenterology and Hepatology
Integrative Medicine

Background:

Complementary and alternative medicine (CAM) use is increasing among patients.
Western medical practitioners require knowledge of CAM literature for informed patient care.
Research in CAM for gastrointestinal and liver diseases is expanding but often lacks definitive conclusions.

Purpose of the Study:

To review current knowledge of CAM therapies for functional gastrointestinal disorders, inflammatory bowel disease, and liver disease.
To inform healthcare providers about the evidence base of CAM modalities.
To aid in discussions with patients regarding CAM use.

Main Methods:

Literature review of complementary and alternative medicine therapies.
Focus on functional gastrointestinal disorders, inflammatory bowel disease, and liver disease.
Synthesis of available research findings.

Main Results:

The volume of CAM research in gastrointestinal disorders has grown.
Definitive conclusions on many CAM modalities remain limited.
Evidence for specific CAM therapies varies across conditions.

Conclusions:

Understanding CAM literature is crucial for discussing therapies with patients.
Effective CAM modalities may be integrated into conventional practice.
Risky or ineffective CAM therapies should be avoided to benefit patients and practitioners.